BDMDBDMDHealthcare · Medical Devices

BDMD Stock Forecast: Baird Medical Investment Holdings Ltd. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$0.09
−12.91% on the day

Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 59 of 100 as at 21 Nov 2026 — in the upper half.

Market cap
$3.3M
Ticker Nerd rank
59/ 100
Median analyst target
$4.00
Analysts covering
—
Total return, dividends reinvested
1W
−1.4%
1M
−81.4%
YTD
−93.4%
1Y
−94.1%
From 52W high
−97.4%
From 52W low
+13.5%
$0.08
$3.44
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Baird Medical Investment Holdings Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
59/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
95
Value
91
Revisions
50
Issuance
50
Quality
35
Momentum
32
Volatility
29
Growth
10

Accruals (95): Reported profit is backed by cash, and the company is not expanding recklessly.

Growth (10): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

BDMD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BDMD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$1.00$2.00$3.00$4.00Jan 26Apr 26Jul 26Oct 26BDMDHigh $4.00Median $4.00Low $4.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

BDMD appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

BDMD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Baird Medical Investment Holdings Ltd. returned −94.1% against +6.9% for the S&P 500, dividends included.

BDMD vs S&P 500, last 12 monthsTotal return, rebased to 100
050100150200Jan 26Apr 26Jul 26Oct 26BDMDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

BDMD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
0
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
0.2×

Cheaper than 89% of US stocks

Price / book
0.1×

Cheaper than 96% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
24.6%

Higher than 74% of US stocks

Earnings growth (YoY)
—
Gross margin
—
Operating margin
−58.5%

Higher than 17% of US stocks

Net margin
−65.1%

Higher than 8% of US stocks

Returns & dividend
Return on equity
−46.0%

Higher than 23% of US stocks

Return on assets
−11.9%

Higher than 25% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Baird Medical Investment Holdings Ltd. has a market value of $3.3M and an enterprise value of $21.6M.

  • Shares outstanding: 30.8M.

  • forward P/E: 0.7× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Baird Medical Investment Holdings Ltd. employs 146 people.

market figures as at 20 Nov 2026

Data provided by Twelve Data

Peers

BDMD and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
BDMDBaird Medical Investment Holdings Ltd.$3.3M59
POASPhaos Technology Holdings (Cayman) Ltd.$5.1M2
BMRABiomerica, Inc.$5.0M11
WOKWORK Medical Technology Group Ltd.$4.9M16
INBSIntelligent Bio Solutions, Inc.$4.6M21
ICCMIceCure Medical Ltd.$4.5M30
VNRXVolitionRX Ltd.$5.8M53

Take a look at BDMD’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Baird Medical Investment Holdings Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about BDMD

How does Ticker Nerd's model rank BDMD?

As at 21 Nov 2026, Baird Medical Investment Holdings Ltd. ranks 59 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (95 of 100).

What is the BDMD stock forecast for 2030?

No analyst covering Baird Medical Investment Holdings Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BDMD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $4 to $4 over the next 12 months.

How has BDMD stock performed over the past year?

Baird Medical Investment Holdings Ltd. returned -94.1% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Baird Medical Investment Holdings Ltd. do?

Baird Medical Investment Holdings Ltd. is a medical technology company focused on the research, development, manufacturing, and sale of microwave ablation devices and related medical products. Its portfolio includes microwave ablation apparatus and needles used in minimally invasive treatment of benign and malignant tumors, such as thyroid nodules, liver cancer, lung cancer, breast lumps, and uterine fibroids.

Company

About Baird Medical Investment Holdings Ltd.

Baird Medical Investment Holdings Ltd. is a medical technology company focused on the research, development, manufacturing, and sale of microwave ablation devices and related medical products. Its portfolio includes microwave ablation apparatus and needles used in minimally invasive treatment of benign and malignant tumors, such as thyroid nodules, liver cancer, lung cancer, breast lumps, and uterine fibroids. The company also develops devices for soft tissue ablation, serving healthcare providers that perform image-guided and minimally invasive procedures. Baird Medical Investment Holdings Ltd. operates in the medical devices sector, where microwave ablation technology plays a specialized role in interventional oncology and other therapeutic applications. Headquartered in Guangzhou, China, the company is positioned around clinically targeted device innovation and distribution for hospital and physician use.

CEO Ms. Haimei Wu · 146 employees · China · https://bairdmed.com